Overview

Evaluating Possible Improvement in Tinnitus Severity After 28 Days Dosing of the Study Drug AUT00063 Compared to Placebo

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This study aims to demonstrate that the new medicine AUT00063 is effective and safe in the treatment of tinnitus.
Phase:
Phase 2
Details
Lead Sponsor:
Autifony Therapeutics Limited
Collaborator:
University of Nottingham